Abstract
Influenza A virus infections are one of the most important factors that are still considered as global health concerns. The best and most effective defense against these infections is vaccination. Due to the limitations of current vaccines, vaccine design based on bioinformatics methods is receiving a lot of attention. Hence, in the present study, using a novel immunoinformatics methodology, we have intentioned an Influenza multi-epitope vaccine based on the greatly conserved and antigenic epitopes of Influenza virus nucleoprotein. The nucleoprotein (NP) of Influenza A virus displays an essential character in the vital functions of the virus so it can be used as a goal protein for vaccine design. The purpose of this vaccine is to induce humoral and cellular immune responses through epitopes in the np protein against influenza A viruses. Nucleoprotein sequences were analyzed by in-silico tools to predict and identify the most immunogenic B and T cell epitopes. The multi-epitope vaccine was designed using specific and proper linkers. We also explored the physicochemical properties of the planned construct to approve its thermodynamic stability, hydrophilicity, PI, antigenicity, and allergenicity. In addition, the modeled and optimized tertiary structure was predicted to be usable for further procedure. The molecular docking of the TLR3/4 and designed vaccine illustrates engaged binding. Taken together, these outcomes propose that the structure of our multi-epitope vaccine may offer strong immunizations beside dissimilar strains of influenza virus subtypes, thus evading the requirement for yearly vaccine re-formulation.
Similar content being viewed by others
References
Ahmad S, Shahid F, Tahir ul Qamar M, Rehman H, Abbasi SW, Sajjad W, Ismail S, Alrumaihi F, Allemailem KS, Almatroudi A (2021) Immuno-informatics analysis of PAKISTAN-based HCV subtype-3a for chimeric polypeptide vaccine design. Vaccines 9(3):293
Al Hassan YT, Fabella EL, Estrella ED, Al Ramadan HA, Al Rajeh AM, Al Saleh FH (2021) Association of vaccine awareness and confidence on the influenza vaccination status of Al Ahsa, Saudi Arabia residents. Hum Vacc Immunother 17(7):2190–2196
Alam A, Ali S, Ahamad S, Malik MZ, Ishrat R (2016) From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein. Immunology 149(4):386–399
Bahrami AA, Bandehpour M, Khalesi B, Kazemi B (2020) Computational design and analysis of a poly-epitope fusion protein: a new vaccine candidate for Hepatitis and Poliovirus. Int J Pept Res Ther 26(1):389–403
Bassani-Sternberg M, Gfeller D (2016) Unsupervised HLA peptidome deconvolution improves ligand prediction accuracy and predicts cooperative effects in peptide–HLA interactions. J Immunol 197(6):2492–2499
Behbahani M, Moradi M, Mohabatkar H (2021) In silico design of a multi-epitope peptide construct as a potential vaccine candidate for Influenza A based on neuraminidase protein. In Silico Pharmacol 9(1):1–13
Bhatnager R, Bhasin M, Arora J, Dang AS (2021) Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach. J Biomol Struct Dyn 39(15):5690–5705
Bibi S, Ullah I, Zhu B, Adnan M, Liaqat R, Kong W-B, Niu S (2021) In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci Rep 11(1):1–16
Biswas A, Chakrabarti AK, Dutta S (2020) Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines: flu vaccine efficacy encounters significant hurdles from pre-existing immunity of the host suggesting assessment of host immunity before vaccination. Int Rev Immunol 39(1):21–36
Chang D, Zaia J (2019) Why glycosylation matters in building a better flu vaccine. Mol Cell Proteomics 18(12):2348–2358
Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO (2020) Nanotechnology for COVID-19: therapeutics and vaccine research. ACS Nano 14(7):7760–7782
Choudhary MI, Shaikh M, tul-Wahab A, ur-Rahman A (2020) In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. PLoS ONE 15(7):e0235030
Clark DR, McKew BA, Binley A, Heppell CM, Whitby C, Trimmer M (2022) Hydrological properties predict the composition of microbial communities cycling methane and nitrogen in rivers. ISME Communications 2(1):1–9
Cohen IR, Efroni S (2019) The immune system computes the state of the body: crowd wisdom, machine learning, and immune cell reference repertoires help manage inflammation. Front Immunol 10:10
Dewi IP (2017) B-cell epitope prediction of Mycobacterium tuberculosis Ag85A antigen. UNEJ e-Proceeding, pp 108–111
Dhanda SK, Mahajan S, Paul S, Yan Z, Kim H, Jespersen MC, Jurtz V, Andreatta M, Greenbaum JA, Marcatili P (2019) IEDB-AR: immune epitope database—analysis resource in 2019. Nucleic Acids Res 47(W1):W502–W506
Ebrahim-Saraie HS, Dehghani B, Mojtahedi A, Shenagari M, Hasannejad-Bibalan M (2021) Functional and structural characterization of SARS-cov-2 spike protein: an in silico study. Ethiopian J Health Sci 31(2)
Eisfeld AJ, Neumann G, Kawaoka Y (2015) At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol 13(1):28–41
Englmeier L (2020) A theory on SARS-CoV-2 susceptibility: low sensitivity of tlr7-signalling as a mechanistic explanation for the increased risk of obese and elderly COVID-19 patients."
Fotouhi F, Shaffifar M, Farahmand B, Shirian S, Saeidi M, Tabarraei A, Gorji A, Ghaemi A (2017) Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus. Adv Virol 162(5):1251–1260
Foy BH, Wahl B, Mehta K, Shet A, Menon GI, Britto C (2021) Comparing COVID-19 vaccine allocation strategies in India: a mathematical modelling study. Int J Infect Dis 103:431–438
Girija AS, Shoba G, Priyadharsini JV (2021) Accessing the T-Cell and B-Cell immuno-dominant peptides from A. baumannii biofilm associated protein (bap) as vaccine candidates: a computational approach. Int J Pept Res Ther 27(1):37–45
Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, Simpson TL (2018) Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin Psychol Rev 59:52–60
Han VX, Jones HF, Patel S, Mohammad SS, Hofer MJ, Alshammery S, Maple-Brown E, Gold W, Brilot F, Dale RC (2022) Emerging evidence of Toll-like receptors as a putative pathway linking maternal inflammation and neurodevelopmental disorders in human offspring: a systematic review. Brain Behav Immun 99:91–105
Hu Z, van der Ploeg K, Chakraborty S, Arunachalam P, Mori DM, Jacobson KB, Bonilla H, Parsonnet J, Andrews J, Hedlin H (2021) Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19. medRxiv
Iwasaki A, Pillai PS (2014) Innate immunity to influenza virus infection. Nat Rev Immunol 14(5):315–328
Jabalia N, Kumar A, Kumar V, Rani R (2021). In silico approach in drug design and drug discovery: an update. In: Innovations and implementations of computer aided drug discovery strategies in rational drug design. Springer, pp 245–271
Joshi A, Joshi BC, Mannan MA-U, Kaushik V (2020) Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach. Inform Med Unlocked 19:100338
Kumar TA (2013) CFSSP: Chou and Fasman secondary structure prediction server. Wide Spectrum 1(9):15–19
Kumar AU, Kadiresen K, Gan WC, Ling APK (2021) Current updates and research on plant-based vaccines for coronavirus disease 2019. Clin Exp Vacc Res 10(1):13
Kumar A, Sharma P, Arun A, Meena LS (2022) Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against Mycobacterium tuberculosis H37Rv: an immuno-informatics approach. J Biomol Struct Dyn 4:1–23
Laskowski RA, Jabłońska J, Pravda L, Vařeková RS, Thornton JM (2018) PDBsum: structural summaries of PDB entries. Protein Sci 27(1):129–134
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X (2020a) Coronavirus infections and immune responses. J Med Virol 92(4):424–432
Li Q-Y, Xu M-M, Dong H, Zhao J-H, Xing J-H, Wang G, Yao J-Y, Huang H-B, Shi C-W, Jiang Y-L (2020b) Lactobacillus plantarum surface-displayed influenza antigens (NP-M2) with FliC flagellin stimulate generally protective immune responses against H9N2 influenza subtypes in chickens. Vet Microbiol 249:108834
Liu C-Y, Yang Y, Zhang X-M, Xu X, Dou Q-L, Zhang W-W, Cheng AS (2020) The prevalence and influencing factors in anxiety in medical workers fighting COVID-19 in China: a cross-sectional survey. Epidemiol Infect. https://doi.org/10.1017/S0950268820001107
Mahant S, Sahajpal NS, Nanda S (2021) Insights into the mechanism of Cymbopogan martinii essential oil in topical therapy of acne vulgaris. Fut Microbiol 16(15):1181–1193
Maleki A, Russo G, Parasiliti Palumbo GA, Pappalardo F (2021) In silico design of recombinant multi-epitope vaccine against influenza A virus. BMC Bioinform 22(14):1–19
Massari S, Desantis J, Nizi MG, Cecchetti V, Tabarrini O (2020) Inhibition of influenza virus polymerase by interfering with its protein–protein interactions. ACS Infect Dis 7(6):1332–1350
Patel MC, Shirey KA, Pletneva LM, Boukhvalova MS, Garzino-Demo A, Vogel SN, Blanco JC (2014) Novel drugs targeting Toll-like receptors for antiviral therapy. Futur Virol 9(9):811–829
Paul D, Sharif IH, Sayem A, Ahmed H, Saleh A, Mahmud S (2021). In silico prediction of a highly immunogenic and conserved epitope against Zika Virus. Inform Med Unlocked 100613
Plociennikowska A, Frankish J, Moraes T, Del Prete D, Kahnt F, Acuna C, Slezak M, Binder M, Bartenschlager R (2021) TLR3 activation by Zika virus stimulates inflammatory cytokine production which dampens the antiviral response induced by RIG-I-like receptors. J Virol 95(10):e01050-e11020
Prajapat R, Marwal A, Gaur R (2014) Recognition of errors in the refinement and validation of three-dimensional structures of AC1 proteins of begomovirus strains by using ProSA-Web. J Virus 2014:1–6
Qamar MTU, Saba Ismail SA, Mirza MU, Abbasi SW, Ashfaq UA, Chen L-L (2021) Development of a novel multi-epitope vaccine against crimean-congo hemorrhagic fever virus: an integrated reverse vaccinology, vaccine informatics and biophysics approach. Front Immunol. https://doi.org/10.3389/fimmu.2021.669812
Rostaminia S, Aghaei SS, Farahmand B, Nazari R, Ghaemi A (2021) Computational design and analysis of a multi-epitope against influenza A virus. Int J Pept Res Therap 27:2625–2638
Sabbaghi A, Zargar M, Zolfaghari MR, Motamedi-Sedeh F, Ghaemi A (2021) Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model. Adv Virol 166(2):545–557
Samad A, Ahammad F, Nain Z, Alam R, Imon RR, Hasan M, Rahman MS (2020) Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2020.1792347
Samad A, Ahammad F, Nain Z, Alam R, Imon RR, Hasan M, Rahman MS (2022) Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach. J Biomol Struct Dyn 40(1):14–30
Schlessinger A, Yachdav G, Rost B (2006) PROFbval: predict flexible and rigid residues in proteins. Bioinformatics 22(7):891–893
Selvaraj P, Lien CZ, Liu S, Stauft CB, Nunez IA, Hernandez M, Nimako E, Ortega MA, Starost MF, Dennis JU (2021) SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters. Life Sci Allianc 4(4):e202000886
Shafiuddin M, Boon AC (2019) RNA Sequence features are at the core of influenza A virus genome packaging. J Mol Biol 431(21):4217–4228
Shahid F, Ashfaq UA, Javaid A, Khalid H (2020) Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome. Infect Genet Evol 80:104199
Sharma S, Kumari V, Kumbhar BV, Mukherjee A, Pandey R, Kondabagil K (2021) Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus. Immunobiology 226(2):152053
Tsai SP, Howell DW, Huang Z, Hsiao HC, Lu Y, Matthews KS, Lou J, Bondos SE (2015) The effect of protein fusions on the production and mechanical properties of protein-based materials. Adv Funct Mater 25(9):1442–1450
Wang V, Xu N, Liu J-C, Tang G, Geng W-T (2021) VASPKIT: a user-friendly interface facilitating high-throughput computing and analysis using VASP code. Comput Phys Commun 267:108033
Weng G, Gao J, Wang Z, Wang E, Hu X, Yao X, Cao D, Hou T (2020) Comprehensive evaluation of fourteen docking programs on protein–peptide complexes. J Chem Theory Comput 16(6):3959–3969
Wu J, Chen ZJ (2014) Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 32:461–488
Yan Y, Tao H, He J, Huang S-Y (2020) The HDOCK server for integrated protein–protein docking. Nat Protoc 15(5):1829–1852
Yang F, Pang B, Lai KK, Cheung NN, Dai J, Zhang W, Zhang J, Chan K-H, Chen H, Sze K-H (2021) Discovery of a Novel specific inhibitor targeting influenza A Virus nucleoprotein with pleiotropic inhibitory effects on various steps of the viral life cycle. J Virol 95(9):e01432-e11420
Acknowledgements
The authors would like to acknowledgement Pasteur institute of Iran for the financial support.
Funding
This work was supported by Pasteur Institute of Iran (Grant 1137).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
Authors declare there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rostaminia, S., Aghaei, S.S., Farahmand, B. et al. In-Silico Design of a Multi‑epitope Construct Against Influenza A Based on Nucleoprotein Gene. Int J Pept Res Ther 28, 117 (2022). https://doi.org/10.1007/s10989-022-10418-w
Accepted:
Published:
DOI: https://doi.org/10.1007/s10989-022-10418-w